Compare Abeona Therapeutics Inc (ABEO) vs GE Vernova Inc (GEV) Price & Performance

Abeona Therapeutics IncTrade

GE Vernova IncTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs GE Vernova Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while GE Vernova Inc trades at $1,044.78 (market cap $269.50B). The key difference: GE Vernova Inc is far larger — about 639.9× Abeona Therapeutics Inc's market cap, and GE Vernova Inc pays a 0.2% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.

	ABEO	GEV
Market Cap	$421.19M	$269.50B
Sector	Health	Technology
52-Week High	$7.45	$1.17K
52-Week Low	$4.17	$547.96
Enterprise Value	$276.10M	$259.17B
Dividend Yield	—	0.2%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABEO

View details →

GEV

GE Vernova benefits from AI-driven power and grid bottlenecks but faces high expectations at 28x 2028 earnings.Seeking Alpha · 8 hours agoNeutral Invesco S&P 500 Equal Weight Energy ETF rated Buy for balanced energy sector exposure amid oil market shifts.Seeking Alpha · 1 day agoBullish View details →

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

About GE Vernova Inc

GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.